News
$Orchestra BioMed (OBIO.US)$ The FDA Granted An Investigational Device Exemption To Initiate BACKBEAT Study Evaluating Orchestra Biomed's Atrioventricular Interval Modulation Therapy (BACKBEAT CNT) For Hypertensive Patients Who Are Indicated For A Dual-chamber Cardiac Pacemaker
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more